Dr Reddy's Laboratories Ltd ADR

RDY: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|.TnLOCK|%<LOCK|m%!!Z&<

Dr. Reddy's Earnings: Lenalidomide's Slide Digs Into Numbers, but Base Business Remains Solid

Dr. Reddy's reported a 12% quarterly revenue decline and a diluted EPS of INR 2.6. Both figures landed below FactSet consensus. Shares are down 6%.

Sponsor Center